Furthermore, the more prominent repression of MAST4 in cell lines carrying the risk genotype by glucocorticoids, a risk hormone for breast cancer metastasis (16), fits with the fact that lower expression of MAST4 was observed in breast cancer tissues and was associated with worse treatment outcomes in breast cancer patients. This evidence concerns the gene MAST4 and breast cancer.